Dexmedetomidine or Clonidine Infusion for Prevention of Delirium After Open Heart Surgery
Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
A parallel-group treatment, five-centre, participant and investigator masked, three-arm study
to assess the safety and effectiveness of dexmedetomidine or clonidine infusion compared to
placebo for the prevention of delirium and cognitive decline in male and female participants
aged 70+ scheduled for open heart surgery.
Phase:
Phase 4
Details
Lead Sponsor:
Oslo University Hospital
Collaborators:
Haukeland University Hospital Sahlgrenska University Hospital, Sweden St. Olavs Hospital UMC Utrecht University Hospital of North Norway